STOCK PURCHASE AGREEMENTStock Purchase Agreement • January 10th, 2017 • RXi Pharmaceuticals Corp • Pharmaceutical preparations • Delaware
THIS STOCK PURCHASE AGREEMENT, dated as of January 6, 2017 (this “Agreement”), is by and among RXi Pharmaceuticals Corporation, a Delaware corporation (the “Buyer”), RXi Merger Sub, LLC, a Delaware limited liability company and wholly owned Subsidiary of Buyer (“Merger Sub”), MirImmune Inc., a Delaware corporation (the “Company”), the stockholders of the Company set forth on the signature pages hereto (each a “Seller” and collectively, the “Sellers”), and Alexey Wolfson, Ph.D. in his capacity as the Sellers’ Representative (the “Sellers’ Representative”). The Buyer, the Company and the Sellers are each referred to as a “Party” and collectively as the “Parties.”
